Literature DB >> 31698021

Critical Role of Oxidatively Damaged DNA in Selective Noradrenergic Vulnerability.

Yanqiang Zhan1, Muhammad U Raza2, Lian Yuan2, Meng-Yang Zhu3.   

Abstract

An important pathology in Parkinson's disease (PD) is the earlier and more severe degeneration of noradrenergic neurons in the locus coeruleus (LC) than dopaminergic neurons in the substantia nigra. However, the basis of such selective vulnerability to insults remains obscure. Using noradrenergic and dopaminergic cell lines, as well as primary neuronal cultures from rat LC and ventral mesencephalon (VM), the present study compared oxidative DNA damage response markers after exposure of these cells to hydrogen peroxide (H2O2). The results showed that H2O2 treatment resulted in more severe cell death in noradrenergic cell lines SK-N-BE(2)-M17 and PC12 than dopaminergic MN9D cells. Furthermore, there were higher levels of oxidative DNA damage response markers in noradrenergic cells and primary neuronal cultures from the LC than dopaminergic cells and primary cultures from the VM. It included increased tail moments and tail lengths in Comet assay, and increased protein levels of phosphor-p53 and γ-H2AX after treatments with H2O2. Consistent with these measurements, exposure of SK-N-BE(2)-M17 cells to H2O2 resulted in higher levels of reactive oxygen species (ROS). Further experiments showed that exposure of SK-N-BE(2)-M17 cells to H2O2 caused an increased level of noradrenergic transporter, reduced protein levels of copper transporter (Ctr1) and 8-oxoGua DNA glycosylase, as well as amplified levels of Cav1.2 and Cav1.3 expression. Taken together, these experiments indicated that noradrenergic neuronal cells seem to be more vulnerable to oxidative damage than dopaminergic neurons, which may be related to the intrinsic characteristics of noradrenergic neuronal cells.
Copyright © 2019 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ca(2+) channels; DNA damage; dopamine; dopamine β-hydroxylase; norepinephrine; vulnerability

Mesh:

Substances:

Year:  2019        PMID: 31698021      PMCID: PMC9338788          DOI: 10.1016/j.neuroscience.2019.09.036

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.708


  118 in total

1.  Effects of DSP4 on the noradrenergic phenotypes and its potential molecular mechanisms in SH-SY5Y cells.

Authors:  Yan Wang; Phillip R Musich; Moises A Serrano; Yue Zou; Jia Zhang; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2013-08-31       Impact factor: 3.911

2.  Locus coeruleus and norepinephrine in Parkinson's disease.

Authors:  V Chan-Palay
Journal:  Jpn J Psychiatry Neurol       Date:  1991-06

3.  Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease.

Authors:  E Bertrand; W Lechowicz; G M Szpak; J Dymecki
Journal:  Folia Neuropathol       Date:  1997       Impact factor: 2.038

4.  Phox2 and dHAND transcription factors select shared and unique target genes in the noradrenergic cell type.

Authors:  Jennifer L Rychlik; Marlene Hsieh; Lee E Eiden; Elaine J Lewis
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

Authors:  Z I Alam; A Jenner; S E Daniel; A J Lees; N Cairns; C D Marsden; P Jenner; B Halliwell
Journal:  J Neurochem       Date:  1997-09       Impact factor: 5.372

Review 6.  Physiological phenotype and vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez; Paul T Schumacker
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 7.  Oxidative damage to purines in DNA: role of mammalian Ogg1.

Authors:  Arne Klungland; Svein Bjelland
Journal:  DNA Repair (Amst)       Date:  2006-11-28

8.  Localization of copper and copper transporters in the human brain.

Authors:  Katherine M Davies; Dominic J Hare; Veronica Cottam; Nicholas Chen; Leon Hilgers; Glenda Halliday; Julian F B Mercer; Kay L Double
Journal:  Metallomics       Date:  2013-01       Impact factor: 4.526

9.  High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.

Authors:  Andreas Bender; Kim J Krishnan; Christopher M Morris; Geoffrey A Taylor; Amy K Reeve; Robert H Perry; Evelyn Jaros; Joshua S Hersheson; Joanne Betts; Thomas Klopstock; Robert W Taylor; Douglass M Turnbull
Journal:  Nat Genet       Date:  2006-04-09       Impact factor: 38.330

10.  Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists.

Authors:  Steven P Presgraves; Tariq Ahmed; Sabine Borwege; Jeffrey N Joyce
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.978

View more
  2 in total

Review 1.  Parkinson disease-associated cognitive impairment.

Authors:  Dag Aarsland; Lucia Batzu; Glenda M Halliday; Gert J Geurtsen; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub
Journal:  Nat Rev Dis Primers       Date:  2021-07-01       Impact factor: 52.329

Review 2.  The Phosphorylated Form of the Histone H2AX (γH2AX) in the Brain from Embryonic Life to Old Age.

Authors:  Adalberto Merighi; Nadia Gionchiglia; Alberto Granato; Laura Lossi
Journal:  Molecules       Date:  2021-11-27       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.